cartilag regener requir balanc anabol catabol process examin suscept fibromodulin fmod lumican lum degrad mmp13 adamts4 adamts5 three major degrad proteinas articular cartilag cartilag develop osteoarthr immunoloc fmod lum fetal foot adult knee cartilag use fmod matrix metalloproteas mmp13 neoepitop antibodi tsyg11 ctermin antifmod pr184 antilum pr353 antibodi vitro digest knee cartilag mmp13 disintegrin metalloproteas thrompospondin motif adamts4 adamts5 assess whether fmod lum fragment observ western blot total knee replac specimen could gener normal ovin articular cartilag explant cultur interleukin il1 oncostatinm osm pge3162689 broad spectrum mmp inhibitor assess fmod lum collagen degrad fmod lum immunoloc metatars phalang fetal rudiment cartilag growth plate antibodi tsyg11 local mmp13cleav fmod hypertroph chondrocyt metatars growth plate fmod promin local superfici cartilag normal fibril zone cartilag tsyg11posit fmod locat deep cartilag sampl tsyg11 identifi fmod fragment western blot normal fibril cartilag extract total knee replac cartilag ctermin antifmod pr184 fail identifi fmod fragment due ctermin process ctermin lum pr353 identifi three lum fragment cartilag vitro digest human knee cartilag mmp13 adamts4 adamts5 gener fmod fragment kda similar blot cartilag lum less suscept fragment pr353 detect ntermin process lum fragment kda 6580yearold knee replac cartilag fmod lum differenti process mmp13 adamts4 adamts5 digest fmod suscept degrad mmp13 adamts4 lesser extent adamts5 howev lum mmp13cleav fmod metatars phalang fetal rudiment growth plate cartilag suggest role skeletogenesi pathogenesi explant cultur ovin cartilag stimul il1osm pge3162689 display gag loss day due adamt activ howev day activ prommp occur well degrad fmod collagen chang inhibit pge3162689 partli explain fmod fragment seen potenti therapeut util pge3162689 
matrix metalloproteinas mmp class zinc depend endopeptidas play crucial role multitud sever diseas cancer osteoarthr employ mmp13 target enzym structurebas design synthesi inhibitor abl recogn catalyt zinc ion addit alloster bind site order increas affin ligand guid molecular model optim initi alloster inhibitor addit linker fragment weak zinc binder recognit catalyt center furthermor improv lipophil ligand effici lle initi inhibitor appropri zinc bind fragment lower clogp valu inhibitor maintain potenc synthes inhibitor show elev affin compar initi hit also novel inhibitor display better lle deriv carboxyl acid zinc bind fragment turn potent inhibitor compound zhawoc5077 ic50 134 wherea acyl sulfonamid show best lipophil ligand effici compound zhawoc5135 lle 291 
sustain inflamm matrix metalloproteinas mmp activ contribut vascular occlusiveprolif disord interleukin17 il17 proinflammatori cytokin signal mainli via traf3 interact protein traf3ip2 upstream regul variou critic transcript factor includ ap1 nfb reversionxa0induc cysteinexa0rich protein kazal motif reck membraneanchor mmp inhibitor investig whether il17atraf3ip2 signal promot mmp13depend human aortic smooth muscl cell smc prolifer migrat determin whether reck overexpress blunt respons inde il17a treatment induc jnk p38 mapk ap1 nfb creb activ mir21 induct mir27b mir320 inhibit mmp13 express activ reck suppress smc migrat prolifer traf3ip2depend manner fact gain trag3ip2 function induc mmp13 express activ reck suppress furthermor treatment recombin mmp13 stimul smc migrat part via erk activ importantli reck gainoffunct attenu mmp13 activ without affect mrna protein level inhibit il17a mmp13induc smc migrat result indic increas mmp13 decreas reck contribut il17ainduc traf3ip2depend smc migrat prolifer suggest traf3ip2 inhibitor reck induc potenti block progress neointim thicken hyperplast vascular diseas 
complic diabet neuropathi condit sensori axon degener origin epidermi mechan remain unknown reactiv oxygen speci implic thi condit thi studi assess role candid downstream target mmp13 glucoseinduc sensori axon degener zebrafish mice effect glucos metabol sensori axon degener assess use qpcr live imag analyz use pentafluorobenzenesulfonyl fluorescein activ nfb stress respons determin use tgnfbgfp zebrafish role mmp13 glucosedepend axon degener determin zebrafish follow treatment antioxid nacetylcystein mmp13 inhibitor db04760 neuropath mice fed highfathighsugar diet treat mmp13 inhibitor cl82198 assess sensori recoveri glucos treatment zebrafish induc metabol chang resembl diabet sensori axon degener mediat rosinduc mmp13 prevent upon antioxid treatment mmp13 inhibit mmp13 inhibit also revers neuropathi diabet mice demonstr zebrafish suitabl studi glucoseinduc neurotox given effect zebrafish mice mmp13 inhibit may benefici treatment human diabet neuropathi 
adam8 report promot extracellular matrix degrad provid condit tumor metastasi howev underli mechan adam8 modul chondrosarcoma metastasi remain unclear use two human cell line sw1353 hcs28 analyz express profil adam8 cell compar normal chondrocyt import proteolyt enzym mmp13 detect marker extracellular matrix degrad chondrocyt silenc overexpress adam8 effect cell migrat invas sw1353 hcs28 downstream signal transduct pathway evalu adam8 mmp13 highli express nfb pathway activ sw1353 hcs28 cell silenc adam8 significantli reduc abil cell migrat invas block nfb signal pathway p65 dephosphoryl lead reduc nfb transcript activ decreas mmp13 express adam8 overexpress promot process howev revers inhibitor bay 117085 data show novel regul mechan adam8 promot migrat invas activ nfbmmp13 signal axi modul level may serv potenti target treatment even cartilag diseas 
patholog progress osteoarthr involv degrad articular cartilag matrix type collagen main compon cartilag matrix degrad proinflammatori cytokin il1 mediat mmp13 nebivolol licens drug use treatment hypertens clinic display antiinflammatori capac variou condit howev whether nebivolol protect effect cartilag matrix degrad report befor thi studi investig effect nebivolol regul express mmp13 degrad type collagen result indic nebivolol allevi increas gene express protein express activ mmp13 induc il1 importantli il1 strikingli reduc level type collagen cell cultur supernat revers treatment nebivolol dosedepend manner mechanist nebivolol found allevi increas level phosphoryl reduc level total induc il1 subsequ mitig p65 nuclear transloc transcript activ nfb furthermor result indic il1 treatment result signific increas express transcript factor interferon regulatori factor1 irf1 mrna protein level significantli amelior treatment nebivolol combin find suggest nebivolol potenti appli human treatment 
matrix metalloproteinas mmp inhibitor play role pathobiolog retin detach prolif vitreoretinopathi pvr prolif vitreoretinopathi facilit chronic retin detach involv excess deposit extracellular matrix ecm protein matrix metalloproteinase2 import modul ecm evalu purpos thi studi investig retin express select mmp includ mmp12 mmp13 associ inhibitor murin model retin detach transient chronic retin detach induc subretin inject either salin hyaluron acid c57bl6 mice confirm hard model featur consist pvrlike chang glial activ subretin fibrosi evalu immunofluoresc dilat fundu examin spectraldomain optic coher tomographi sdoct gene express quantifi qrtpcr protein assay immunoblot immunohistochemistri hyaluron acid eye develop gliosi subretin fibrosi dilat exam sdoct immunofluoresc analysi gene express mmp12 mmp13 timp1 strongli upregul time point compar control timp2 mmp2 mmp9 express modest hyaluron acid exhibit mmp timp express sard mmp12 timp1 protein elev compar control immunohistochemistri reveal moder strong mmp13 level subretin space macrophag fibrosi develop hard model upregul select mmp may modul wound heal process follow 
matrix metalloproteinase13 mmp13 attract drug target treatment osteoarthr thi studi seri quinazolinon deriv mmp13 inhibitor firstli systemat studi use qsar molecular dock molecular dynam simul reliabl comfa iqisup2sup 0646 irisup2sup 0992 irisubpredsubsup2sup 0829 comsia iqisup2sup 0704 irisup2sup 0992 irisubpredsubsup2sup 0839 model construct verifi topom comfa model result contour map indic electrostat hydrophob hbond acceptor field primarili influenc activ mmp13 inhibitor model sever key residu ala238 thr245 thr247 met253 asn215 lys140 identifi import factor improv activ stabil inhibitor hydrogen bond electrostat interact base result eight novel quinazolinon bd1d8b design addit design compound show good pharmacokinet properti admet predict compound bd3b bd8b exhibit excel predict activ simul analysi reveal hydrogen bond interact residu ser250 gly248 enhanc small group ushap conform pivot import result provid strong guidanc discoveri design novel potenti mmp13 inhibitor 
matrix metalloproteinas like mmp13 cleav remodel extracellular matrix therebi play crucial role tumor progress vivo use highli select inhibitor block mmp13 protein activ demonstr strike inhibitori effect invas tumor growth vascular murin skin squamou cell carcinoma scc therapi outcom critic depend anim age c57bl6 mice success old femal young femal mice treatment success recov ovariectomi young abolish 17estradiol supplement old mice suggest hormon depend inhibitor effect respons tumorigen keratinocyt bdvii fibroblast 17estradiol confirm vitro mmp13 inhibitor treatment led reduct cell invas vascular endotheli growth factor vegf releas thi correl well less invas vascular tumor treat mice vivo 17estradiol supplement also reduc invas vegf releas vitro addit reduct mmp13 inhibitor treatment thi suggest low 17estradiol level old mice vivo lead enhanc mmp13 level vegf releas allow effect inhibitor treatment compar young mice studi present strong link lower estrogen level old femal mice elev mmp13 level result effect mmp13 inhibitor treatment fibroblast scc cell vitro vivo 
adipos tissu remodel matrix metalloproteas mmp critic tissu hypertrophi obes mmp13 import protein highli express adipos tissu whose potenti role adipos tissu expans poorli character investig effect pharmacolog inhibit mmp13 select inhibitor cp544439 adipos tissu mass mice high fat diet determin effect inhibitor dure vitro adipocyt differenti 3t3l1 cell cp544439 administ week mice high fat diet bodi adipos glucos toler determin differenti 3t3l1 adipocyt also treat inhibitor maximum day adipogenesi assess treatment mice inhibitor result reduct bodi adipos improv glucos clearanc histolog examin epididym adipos show reduc adipocyt hypertrophi accompani increas stain collagen inhibitor treat mice treatment differenti 3t3l1 cell inhibitor result reduc adipocyt differenti knockdown mmp13 use small interf rna differenti 3t3l1 cell reduc adipocyt differenti indic reduc express ppar result suggest mmp13 may play major role adipos develop inhibit could potenti strategi prevent obes 
